Annual report pursuant to Section 13 and 15(d)

Note 18 - Fair Values of Financial Instruments (Details Textual)

v3.20.1
Note 18 - Fair Values of Financial Instruments (Details Textual) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Additions, Additional Credit Losses $ 0 $ 0
Available-for-sale Securities, Amortized Cost Basis, Total 2,200 3,500
Impaired Financing Receivable, Recorded Investment, Total 7,220  
Impaired Financing Receivable, Related Allowance 166 246
Impaired Financing Receivable, Fair Value $ 7,100 5,500
Impaired Financing Receivable, with Related Allowance, Unpaid Principal Balance   $ 5,780